Visceral Obesity The Link Among Inflammation, Hypertension, and Cardiovascular Disease

被引:351
作者
Mathieu, Patrick [1 ]
Poirier, Paul [4 ]
Pibarot, Philippe [3 ]
Lemieux, Isabelle [2 ]
Despres, Jean-Pierre [2 ]
机构
[1] Univ Laval, Hop Laval, Quebec Heart Inst, Res Ctr,Dept Surg, Ste Foy, PQ G1V 4G5, Canada
[2] Univ Laval, Hop Laval, Quebec Heart Inst, Res Ctr,Div Kinesiol,Dept Social & Prevent Med, Ste Foy, PQ G1V 4G5, Canada
[3] Univ Laval, Hop Laval, Quebec Heart Inst, Res Ctr,Dept Med, Ste Foy, PQ G1V 4G5, Canada
[4] Univ Laval, Hop Laval, Quebec Heart Inst, Res Ctr,Fac Pharm, Ste Foy, PQ G1V 4G5, Canada
关键词
RANDOMIZED CONTROLLED-TRIAL; CORONARY-ARTERY-DISEASE; CANNABINOID-1 RECEPTOR BLOCKER; CARDIOMETABOLIC RISK-FACTORS; TYPE-2; DIABETES-MELLITUS; RENIN-ANGIOTENSIN SYSTEM; HIGH BLOOD-PRESSURE; WEIGHT-LOSS; METABOLIC SYNDROME; ABDOMINAL OBESITY;
D O I
10.1161/HYPERTENSIONAHA.108.110320
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
[No abstract available]
引用
收藏
页码:577 / 584
页数:8
相关论文
共 56 条
[1]   Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study [J].
Arsenault, Benoit J. ;
Lemieux, Isabelle ;
Despres, Jean-Pierre ;
Wareham, Nicholas J. ;
Luben, Robert ;
Kastelein, John J. P. ;
Khaw, Kay-Tee ;
Boekholdt, S. Matthijs .
EUROPEAN HEART JOURNAL, 2007, 28 (22) :2770-2777
[2]   THE IMPORTANCE OF TRIGLYCERIDES - RESULTS FROM THE PROSPECTIVE CARDIOVASCULAR MUNSTER (PROCAM) STUDY [J].
ASSMANN, G ;
SCHULTE, H .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1992, 8 :99-103
[3]   Differential gene expression between visceral and subcutaneous fat depots [J].
Atzmon, G ;
Yang, XM ;
Muzumdar, R ;
Ma, XH ;
Gabriely, I ;
Barzilai, N .
HORMONE AND METABOLIC RESEARCH, 2002, 34 (11-12) :622-628
[4]   Surgical removal of visceral fat reverses hepatic insulin resistance [J].
Barzilai, N ;
She, L ;
Liu, BQ ;
Vuguin, P ;
Cohen, P ;
Wang, JL ;
Rossetti, L .
DIABETES, 1999, 48 (01) :94-98
[5]   Long-term effects of ramipril on cardiovascular events and on diabetes - Results of the HOPE study extension [J].
Bosch, J ;
Lonn, E ;
Pogue, J ;
Arnold, JMO ;
Dagenais, GR ;
Yusuf, S .
CIRCULATION, 2005, 112 (09) :1339-1346
[6]   Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials [J].
Christensen, Robin ;
Kristensen, Pernelle Kruse ;
Bartels, Else Marie ;
Blidda, Henning ;
Astrup, Arne .
LANCET, 2007, 370 (9600) :1706-1713
[7]   Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men [J].
Cote, M. ;
Matias, I. ;
Lemieux, I. ;
Petrosino, S. ;
Almeras, N. ;
Despres, J-P ;
Di Marzo, V. .
INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (04) :692-699
[8]  
Despres J P, 2006, J Endocrinol Invest, V29, P77
[9]  
Despres Jean-Pierre, 2007, Crit Pathw Cardiol, V6, P51, DOI 10.1097/HPC.0b013e318057d4c9
[10]   Abdominal obesity and metabolic syndrome [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle .
NATURE, 2006, 444 (7121) :881-887